Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
23.23
-0.36 (-1.53%)
At close: Jan 22, 2025, 4:00 PM
23.41
+0.18 (0.77%)
After-hours: Jan 22, 2025, 5:32 PM EST
Immunovant Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Immunovant stock have an average target of 46.11, with a low estimate of 36 and a high estimate of 53. The average target predicts an increase of 98.49% from the current stock price of 23.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunovant stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 6 | 6 | 6 | 5 | 5 |
| Buy | 7 | 5 | 6 | 5 | 6 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 11 | 12 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $45 | Strong Buy | Maintains | $48 → $45 | +93.72% | Jan 15, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $47 → $45 | Buy | Maintains | $47 → $45 | +93.72% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +119.54% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy Initiates $36 | Buy | Initiates | $36 | +54.97% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.03M
EPS This Year
-2.89
from -1.88
EPS Next Year
-3.21
from -2.89
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 65.1M | 150.2M | ||
| Avg | n/a | 7.0M | 48.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 2,036.8% | ||
| Avg | - | - | 590.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.28 | -2.34 | -1.50 | ||
| Avg | -2.89 | -3.21 | -3.16 | ||
| Low | -3.03 | -3.58 | -3.97 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.